Collaborative Arrangements and Acquisitions - Kymera Therapeutics (Details) - Kymera Therapeutics $ in Millions	1 Months Ended
May 31, 2019 USD ($) target
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Collaborative arrangement, up-front payment	$ 50.0
Collaborative arrangement, right to exclusively license, number of targets \| target	6
Collaborative arrangement, development and regulatory potential milestone payments maximum	$ 170.0
Collaborative Arrangement, Investment in Collaborative Partner, Amount	$ 20.0

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Represents the potential milestone amount to be paid by the entity under the collaboration agreement if drug candidates are approved and commercialized.

+ References

No definition available.

+ Details

Name:	vrtx_CollaborativeArrangementDevelopmentAndRegulatoryPotentialMilestonePaymentsMaximum
Namespace Prefix:	vrtx_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Collaborative Arrangement, Investment in Collaborative Partner, Amount

+ References

No definition available.

+ Details

Name:	vrtx_CollaborativeArrangementInvestmentinCollaborativePartnerAmount
Namespace Prefix:	vrtx_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Collaborative Arrangement, Right To License, Number Of Targets

+ References

No definition available.

+ Details

Name:	vrtx_CollaborativeArrangementRightToLicenseNumberOfTargets
Namespace Prefix:	vrtx_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

- Definition

The amount of the up-front license fee paid by the entity pursuant to a collaborative arrangement.

+ References

No definition available.

+ Details

Name:	vrtx_CollaborativeArrangementUpFrontLicenseFee
Namespace Prefix:	vrtx_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Details

Name:	vrtx_CollaborativeArrangementsByAgreementAxis=vrtx_KymeraTherapeuticsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: